Cargando…
Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient
We report the development of a Shiga toxin–producing Escherichia coli O157 gastrointestinal infection associated with hemolytic uremic syndrome in an allogenic stem cell transplant recipient with a history of gastrointestinal graft-vs-host disease receiving long-term immunosuppression.
Autores principales: | Vera-Aguilera, Jesus, Duma, Narjust, Gast, Kelly, Alkhateeb, Hassan, Tande, Aaron, Leung, Nelson, Hogan, William J., Kenderian, Saad J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260488/ https://www.ncbi.nlm.nih.gov/pubmed/30560242 http://dx.doi.org/10.1016/j.mayocpiqo.2018.07.001 |
Ejemplares similares
-
Hemolytic Uremic Syndrome Risk and Escherichia coli O157:H7
por: Tserenpuntsag, Boldtsetseg, et al.
Publicado: (2005) -
An outbreak of hemolytic uremic syndrome due to Escherichia coli O157:H7: or was it?
por: Goldwater, P N, et al.
Publicado: (1996) -
Risk of Hemolytic Uremic Syndrome Related to Treatment of Escherichia coli O157 Infection with Different Antimicrobial Classes
por: Mody, Rajal K., et al.
Publicado: (2021) -
Recurrent Hemolytic and Uremic Syndrome Induced by Escherichia Coli
por: Commereuc, Morgane, et al.
Publicado: (2016) -
Successful Colectomy for Hemorrhagic Colitis with Hemolytic Uremic Syndrome and Acute Encephalopathy due to Escherichia coli O157 Infection
por: Tominaga, Tetsuro, et al.
Publicado: (2014)